JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo RIUMAComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentrosEsta colecciónPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentros

    Mi cuenta

    AccederRegistro

    Estadísticas

    Ver Estadísticas de uso

    DE INTERÉS

    Datos de investigaciónReglamento de ciencia abierta de la UMAPolítica de RIUMAPolitica de datos de investigación en RIUMASHERPA/RoMEODulcinea
    Preguntas frecuentesManual de usoDerechos de autorContacto/Sugerencias
    Ver ítem 
    •   RIUMA Principal
    • Investigación
    • Farmacología y Pediatría - (FP)
    • FP - Artículos
    • Ver ítem
    •   RIUMA Principal
    • Investigación
    • Farmacología y Pediatría - (FP)
    • FP - Artículos
    • Ver ítem

    Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

    • Autor
      Atallah, Edmond; Freixo, Cristiana; Alvarez-Alvarez, Ismael; Cubero, Francisco Javier; Gerbes, Alexander L; [et al.]
    • Fecha
      2021-11-15
    • Editorial/Editor
      Taylor & Francis
    • Palabras clave
      Hígado -- Enfermedades; Medicamentos
    • Resumen
      Introduction: Idiosyncratic drug-induced liver injury (DILI) is an unpredictable event, and there are no specific biomarkers that can distinguish DILI from alternative explanations or predict its clinical outcomes. Areas covered: This systematic review summarizes the available evidence for all biomarkers proposed to have a role in the diagnosis or prognosis of DILI. Following a comprehensive search, we included all types of studies in humans. We included DILI cases based on any threshold criteria but excluded intrinsic DILI, commonly caused by paracetamol overdose. We classified studies into diagnostic and prognostic categories and assessed their methodological quality. After reviewing the literature, 14 studies were eligible. Expert Opinion: Diagnostic studies were heterogeneous with regard to the study population and outcomes measured. Prognostic models were developed by integrating novel biomarkers, risk scores, and traditional biomarkers, which increased their prognostic ability to predict death or transplantation by 6 months. This systematic review highlights the case of need for non-genetic biomarkers that distinguish DILI from acute liver injury related to alternative etiology. Biomarkers with the potential to identify serious adverse outcomes from acute DILI should be validated in independent prospective cohorts with a substantial number of cases.
    • URI
      https://hdl.handle.net/10630/23505
    • DOI
      https://dx.doi.org/10.1080/17425255.2021.1999410
    • Compartir
      RefworksMendeley
    Mostrar el registro completo del ítem
    Ficheros
    Biomarkers of idisyncratic DILI. A systematic review.pdf (979.1Kb)
    Colecciones
    • FP - Artículos

    Estadísticas

    Ver Estadísticas de uso
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
     

     

    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA